| Walmart Pharmacy 10-0073 | |
| 1002 W Taft Ave, Sapulpa, Oklahoma 74066 | |
| (918) 224-2800 |
| Name | Walmart Pharmacy 10-0073 |
|---|---|
| Organization Name | Wal-mart Stores East Lp |
| Location | 1002 W Taft Ave, Sapulpa, Oklahoma 74066 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (918) 224-2800 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced today that it has closed an additional $6 million in its Series C funding round. This brings the total funding raised in the company's series C round to $12.3 million.
As urban populations expand, downtown buildings are going nowhere but up. The huge energy needs of these skyscrapers mean that these towers are not only office buildings, they're polluters with smokestacks billowing out toxins from the rooftop. Our cities are dirtier than we think. New research from Concordia University just might clean them up.
New research findings from fertility experts from Europe, the Americas, Asia & Australasia
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
› Verified 5 days ago
| NPI Number | 1588681696 |
| Organization Name | WAL-MART STORES EAST LP |
| Doing Business As | WALMART PHARMACY 10-0073 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1002 W Taft Ave, Sapulpa, OK 74066 |
| Phone Number | 918-224-2800 |
News Archive
Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced today that it has closed an additional $6 million in its Series C funding round. This brings the total funding raised in the company's series C round to $12.3 million.
As urban populations expand, downtown buildings are going nowhere but up. The huge energy needs of these skyscrapers mean that these towers are not only office buildings, they're polluters with smokestacks billowing out toxins from the rooftop. Our cities are dirtier than we think. New research from Concordia University just might clean them up.
New research findings from fertility experts from Europe, the Americas, Asia & Australasia
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
› Verified 5 days ago
News Archive
Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced today that it has closed an additional $6 million in its Series C funding round. This brings the total funding raised in the company's series C round to $12.3 million.
As urban populations expand, downtown buildings are going nowhere but up. The huge energy needs of these skyscrapers mean that these towers are not only office buildings, they're polluters with smokestacks billowing out toxins from the rooftop. Our cities are dirtier than we think. New research from Concordia University just might clean them up.
New research findings from fertility experts from Europe, the Americas, Asia & Australasia
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.
› Verified 5 days ago
Walgreens #4723 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11 W Taft Ave, Sapulpa, Oklahoma 74066 Phone: (918) 227-0878 | |
Walmart Pharmacy 10-0073 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1002 W Taft Ave, Sapulpa, Oklahoma 74066 Phone: (918) 224-2800 | |
Wal-mart Pharmacy 10-4615 Type: Medicare Supplier Location: 12200 S Waco Ave, Sapulpa, Oklahoma 74066 Phone: (918) 299-8052 | |
Walgreens #15810 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 950 E Taft Ave, Sapulpa, Oklahoma 74066 Phone: (918) 227-7200 | |
Sapulpa Drivein Pharmacy Type: Pharmacy Location: 1029 E Cleveland Ave, Sapulpa, Oklahoma 74066 Phone: (918) 224-6558 |